UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, DC 20549 

FORM 8-K 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the 

Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported) February 26, 2019 

COLGATE-PALMOLIVE COMPANY 

(Exact name of registrant as specified in its charter) 

  [DATA_TABLE_REMOVED] 

 300 Park Avenue, New York, NY 10022 

 (Address of Principal Executive Offices) (Zip Code)  

Registrant’s telephone number, including area code (212) 310-2000 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). 

Emerging growth company o 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o  

 Item 8.01. Other Events.  

On February 26, 2019, Hogan Lovells US LLP delivered its legal opinion with respect to the debt securities (the “Securities”) of Colgate-Palmolive Company (the “Company”), including the Company’s Medium-Term Notes, Series H due one year or more from the date of issue. A copy of the opinion is attached hereto as Exhibit 5.1. 

On February 26, 2019, Hogan Lovells US LLP delivered its legal opinion with respect to the Company’s €500,000,000 aggregate principal amount of 0.500% Medium Term Notes due 2026 (the “2026 Notes”) and €500,000,000 aggregate principal amount of 1.375% Medium Term Notes due 2034 (the “2034 Notes” and, together with the 2026 Notes, the “Notes”). A copy of the opinion is attached hereto as Exhibit 5.2. 

 Item 9.01. Financial Statements and Exhibits.  

(d) Exhibits. The following exhibits are filed as part of this report: 

  [DATA_TABLE_REMOVED]  

2 

SIGNATURE 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

  [DATA_TABLE_REMOVED]  

3